Omega-3 CA did not decrease risk of cardiac events finds STRENGTH trial Hina Zahid18 Nov 2020 4:29 PM ISTDALLAS - The fish oil-based medication known as omega-3 carboxylic acids or omega-3 CA did not decrease the risk of cardiac events compared to a...
Wild Olive Oil reduces BP and prevents retinal damage: Study Dr. Kamal Kant Kohli18 Nov 2020 12:45 PM IST Among the health benefits of extra virgin olive oil, antioxidant, antitumoral and anti-inflammatory properties have been attributed to different...
Sotagliflozin reduces CVD risk in those with diabetes and kidney disease: Study Hina Zahid18 Nov 2020 10:15 AM ISTDALLAS - A novel diabetes medication significantly reduces the risk of hospitalization for heart failure, heart attack and stroke, in patients with...
Rivaroxaban as good as warfarin in AF patients with bioprosthetic mitral valves: RIVER trial Dr Satabdi Saha17 Nov 2020 3:00 PM ISTResearchers have found in The RIVER trial, the largest study that anticoagulant rivaroxaban worked as well as the standard anticoagulant medication...
Children with Kawasaki Disease at higher risk for heart problems 10 years later Hina Zahid17 Nov 2020 2:45 PM ISTATLANTA - New research shows that children with Kawasaki Disease remain at an increased risk for cardiovascular events more than 10 years after...
Lesser risk of recurrent MI with prasugrel than ticagrelor in STEMI patients: Circulation Medha Baranwal17 Nov 2020 2:15 PM ISTGermany: The use of ticagrelor versus prasugrel in STEMI patients undergoing primary PCI did not lead to significant differences in incidence of...
Finerenone reduces risk of cardiac events in Diabetes with CKD: Study Dr Kartikeya Kohli17 Nov 2020 8:38 AM ISTDALLAS - Researchers have found in a large, international clinical trial that novel medication finerenone reduced the rate of death, heart attack,...
Healthy sleep habits associated with lower risk of heart failure: Study Dr. Kamal Kant Kohli16 Nov 2020 6:03 PM ISTDALLAS - Heart failure affects more than 26 million people, and emerging evidence indicates sleep problems may play a role in the development of heart...
90% of Statins related complaints are Nocebo Effect, finds clinical trial Dr. Kamal Kant Kohli16 Nov 2020 5:21 PM ISTStatins are one of the most prescribed drugs to lower LDL cholesterol and risk of cardiovascular disease in high risk patients.Most people tolerate...
CT findings of right heart failure before TAVR predicts mortality, finds study Medha Baranwal16 Nov 2020 4:00 PM ISTUSA: Imaging features of right heart failure seen on CT performed before TAVR is associated with increased death risk within the first year after...
Vitamin D, Omega-3 don't lower atrial fibrillation risk: Study Hina Zahid16 Nov 2020 2:15 PM ISTLOS ANGELES - New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty...
Empagliflozin can treat and reverse heart failure in non-diabetic patients also: Study Dr. Kamal Kant Kohli16 Nov 2020 10:30 AM ISTResearchers at the Icahn School of Medicine at Mount Sinai have found in a new trial known as EMPATROPISM, that diabetes drug Empagliflozin can...
